학술논문
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
Document Type
Academic Journal
Author
Camenzind, Edoardo; Boersma, Eric; Wijns, William; Mauri, Laura; Rademaker-Havinga, Tessa; Ordoubadi, Farzin Fath; Suttorp, Maarten J.; Al Kurdi, Mohammad; Steg, Ph Gabriel; Camenzind, E; Mauri, L; OʼNeill, W; Serruys, P W; Steg, PhG; Wijns, W; Verheugt, FWA; Bertrand, ME; Califf, R; DeMets, D; Wallentin, L; Bocksch, W; Bosmans, J; Garcia, H; Garg, S; Hanet, C; Herrman, J-PR; Kelbaek, H; Mc Fadden, E; Radke, PW; Rutsch, W; Tilsted, HH; Wykrzykowska, J; Alvarez, C; Rodriguez, A; Meredith, I; Muller, D; Whitbourn, R; Worthley, S; Whelan, A; Walters, D; Shetty, S; New, G; Cox, S; Batra, R; van Gaal, W; Bellamy, G; Mayr, H; Heigert, M; Huber, K; Leisch, F; Wijns, W; Desmet, W; Boland, J; Schroeder, E; Chenu, P; Legrand, V; Labinaz, M; Teefy, P; Bertrand, O; Gao, R; Ge, J; Kala, P; Cervinka, P; Ureña, P; Hartikainen, J; Steg, G; Fajadet, J; Carrie, D; Gilard, M; Barragan, P; Lablanche, J-M; Koning, R; Eltchaninoff, H; Darremont, O; Leroy, F; Bertrand, B; Robert, G; Schiele, F; Chassaing, S; Bressollette, E; Brunel, P; Quilliet, L; Brunet, J; Pansieri, M; Sideris, G; Stratiev, V; Teiger, E; Lebreton, H; Bonnet, J-L; Karsenty, B; Delarche, N; Lusson, J-R; Cassagnes, J; Brachmann, J; Kurowski, V; Buerke, M; Schieffer, B; Scholtz, W; Wiemer, M; Fichtlscherer, S; Schächinger, V; Kupatt, C; Boekstegers, P; Genth-Zotz, S; Bode, C; Frey, N; Neumann, F-J; Witzenbichler, B; Pels, K; Strasser, R; Kuck, K-H; Hauptmann, K-E; Baldus, S; Heitzer, T; Haude, M; Hoffmann, E; Jung, W; Hoffmann, S; Schmitt, C; Dissmann, M; Pauschinger, M; Werner, G; Braun-Delleus, R; Burkhardt, D; Manz, M; Voudris, V; Sionis, D; Kang-Yin, M-L; Tse, T-S; Merkely, B; Mehta, A; Parikh, K; Kumar, V; Chandra, P; Rath, P; Hiremath, S; Crean, P; Daly, K; Kornowski, R; Kerner, A; Mosseri, M; Jafari, G; Giudice, P; Trani, C; Manari, A; Prati, F; Pangrazi, A; Bolognese, L; Jeong, M-H; Kim, M-Y; Kim, H-S; Park, S-J; Erglis, A; Kalnins, A; Wagner, D; Zambahari, R; Ong, T-K; Sim, K; den Heijer, P; Appelman, Y; Suttorp, M-J; de Smet, B; Koolen, J; Stella, P; Harding, S; Warwick, J; Maslowski, A; Abernethy, M; Devlin, G; Rotevatn, S; Myreng, Y; Ciecwierz, D; Peruga, J; Reczuch, K; Campante Teles, R; Farto, P; Abreu, E; Leitão-Marques, A; Pereira, H; Vinereanu, D; Alkasab, S; Mhish, H; Al Kurdi, M; Al Turki, F; Wong, P; Teo, S-G; Goicolea Ruigomez, F-J; Valdés Chávarri, M; Bethencourt Gonzalez, A; Iñiguez Romo, A; López Minguez, J; Hernández García, J-M; Diaz Fernández, J; Ruiz Salmeron, R; Martinez Elbal, L; Zueco, J; López-Palop, RF; Melgares, R; Diderholm, E; Kåregren, A; Herterich, O; Olivencrona, G; Fröbert, O; Roffi, M; Verin, V; Girod, G; Vuilliomenet, A; Hsieh, I-C; Wu, C-J; Gershlick, A; Densem, C; Doshi, S; Manoharan, G; McCarthy, P; De Belder, M; Mills, J; Fath-Ordoubadi, F; Simpson, I; Greenwood, J; Chamberlain-Webber, R; Khan, Z; Cotton, J; Gunning, M; Smith, D; Talwar, S; Holmberg, S; Purcell, I; Anderson, R; Alamgir, F; Beatt, K; Kelly, P; Moussavian, M; Aji, J; Prashad, R; Zankar, A; Banerjee, S; Lewis, S; McLaurin, B; Douglas, J; Brener, S; Gupta, A; Walters, L; Driesman, M; Aycock, R; Mego, C; Fisher, D; Frankel, R; Satler, L
Source
European Heart Journal. Aug 01, 2014 35(29):1932-1948
Subject
Language
English
ISSN
0195-668X
Abstract
AIM: To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES) or Cypher sirolimus-eluting stent (C-SES). METHODS AND RESULTS: Of 8709 patients in PROTECT, 4357 were randomized to E-ZES and 4352 to C-SES. Aspirin was to be given indefinitely, and clopidogrel/ticlopidine for ≥3 months or up to 12 months after implantation. Main outcome measures were definite or probable stent thrombosis at 3 years. Multivariable Cox regression analysis was applied, with stent type, DAPT, and their interaction as the main outcome determinants. Dual antiplatelet therapy adherence remained the same in the E-ZES and C-SES groups (79.6% at 1 year, 32.8% at 2 years, and 21.6% at 3 years). We observed a statistically significant (P = 0.0052) heterogeneity in treatment effect of stent type in relation to DAPT. In the absence of DAPT, stent thrombosis was lower with E-ZES vs. C-SES (adjusted hazard ratio 0.38, 95% confidence interval 0.19, 0.75; P = 0.0056). In the presence of DAPT, no difference was found (1.18; 0.79, 1.77; P = 0.43). CONCLUSION: A strong interaction was observed between drug-eluting stent type and DAPT use, most likely prompted by the vascular healing response induced by the implanted DES system. These results suggest that the incidence of stent thrombosis in DES trials should not be evaluated independently of DAPT use, and the optimal duration of DAPT will likely depend upon stent type (Clinicaltrials.gov number NCT00476957).